Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
Jeremy Levin
Teva's new CEO off to shaky start
Teva's new CEO off to shaky start
Globes, Israel
Jeremy Levin
Pharma CEOs
Teva Pharmaceuticals
Difficult Road Ahead For New Teva CEO
Difficult Road Ahead For New Teva CEO
WSJ Online
Bristol-Myers Squibb
Jeremy Levin
Pharma CEOs
Teva Pharmaceuticals
Why Teva Hired A Bristol-Myers Exec As Its CEO
Why Teva Hired A Bristol-Myers Exec As Its CEO
Pharmalot
Bristol-Myers Squibb
Jeremy Levin
Teva Pharmaceuticals
Departure of ’String of Pearls’ Strategist Leaves Gap at Bristol-Myers
Departure of ’String of Pearls’ Strategist Leaves Gap at Bristol-Myers
Bloomberg
Bristol-Myers Squibb
Jeremy Levin
Teva Pharmaceuticals
Bristol’s Acquisition Plans Won’t Change With Loss of Levin to Teva
Bristol’s Acquisition Plans Won’t Change With Loss of Levin to Teva
Bloomberg
Bristol-Myers Squibb
Jeremy Levin
M&A
Teva Pharmaceuticals
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT